1-12 of 12
Iman Jilani, PhD
Close
Sort by
Journal Articles

Clinical Significance of Free Circulating CD4 and CD8 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Adam Abdool, Francis Giles, M.D., Menna Hodge, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Elihu Estey, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 1889.
https://doi.org/10.1182/blood.V108.11.1889.1889
Published: 2006
Journal Articles

Clinical Significance of Free Circulating CD34 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Menna Hodge, Francis Giles, M.D., Adam Abdool, M.D., Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Zeev Estrov, M.D., Elihu Estey, M.D., Hagop Kantarjian, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 4495.
https://doi.org/10.1182/blood.V108.11.4495.4495
Published: 2006
Journal Articles

Variations in Proteasome Enzymatic Activities in Plasma of Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome and Their Value in Predicting Clinical Behavior.

Wanlong Ma, Francis Giles, M.D., Susan O’Brien, M.D., Iman Jilani, PhD, Xi Zhang, Zeev Estrov, M.D., Elihu Estey, M.D., Alessandra Ferrajoli, M.D., Michael Keating, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 4497.
https://doi.org/10.1182/blood.V108.11.4497.4497
Published: 2006
Journal Articles

Clinical Significance of Free Circulating CD33 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Menna Hodge, Francis Giles, M.D., Adam Abdool, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Zeev Estrov, M.D., Elihu Estey, M.D., Hagop Kantarjian, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 4502.
https://doi.org/10.1182/blood.V108.11.4502.4502
Published: 2006
Journal Articles

Measurement and Clinical Relevance of Proteasome Enzymatic Activity in Plasma of Patients with Acute Lymphoblastic Leukemia.

Wanlong Ma, Hagop Kantarjian, M.D., Susan O’Brien, M.D., Iman Jilani, PhD, Xi Zhang, M.D., Zeev Zestrov, M.D., Elihu Estey, M.D, Alessandra Ferrajoli, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 4475.
https://doi.org/10.1182/blood.V108.11.4475.4475
Published: 2006
Journal Articles

Epidermal Growth Factor Is an Independent Prognostic Factor in Patients with Chronic Lymphocytic Leukemia.

Zhong Zhang, MD, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Zeev Estrov, M.D., Alessandra Ferrajoli, M.D., Francis Giles, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 4952.
https://doi.org/10.1182/blood.V108.11.4952.4952
Published: 2006
Journal Articles

Variations in Proteasome Enzymatic Activities in Plasma of Patients with Chronic Lymphocytic Leukemia and Their Value in Predicting Clinical Behavior.

Wanlong Ma, Susan O’Brien, M.D., Iman Jilani, PhD, Xi Zhang, Hagop Kantarjian, M.D., Zeev Estov, M.D., Alessandra Ferrajoli, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 4946.
https://doi.org/10.1182/blood.V108.11.4946.4946
Published: 2006
Journal Articles

Clinical Significance of Free Circulating CD3 and CD5 in Patients with Chronic Lymphocytic Leukemia.

Menna Hodge, Susan O’Brien, M.D., Adam Abdool, Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Alessandra Ferrajoli, M.D., Zeev Estrov, M.D., Francis Giles, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 4947.
https://doi.org/10.1182/blood.V108.11.4947.4947
Published: 2006
Journal Articles

Interleukin-1 Receptor Antagonist and Interleukin-1 beta: Different Roles in Patients with Chronic Lymphocytic Leukemia.

Zhong Zhang, MD, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Zeev Estrov, M.D., Alessandra Ferrajoli, M.D., Francis Giles, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2006) 108 (11): 4948.
https://doi.org/10.1182/blood.V108.11.4948.4948
Published: 2006
Journal Articles

High Levels of Soluble HLA-I in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome: Relevance to Clinical Behavior and b2M Levels.

Maher Albitar, MD, Marcy Johnson, PhD, Kim-Ann Do, PhD, Amanda Day, BS, Iman Jilani, PhD, Sherry Pierce, BS, Elihu Estey, MD, Hagop Kantarjian, MD, Michael Keating, MD, Srdan Verstovsek, MD, Susan O’Brien, MD, Francis J. Giles, MD
Journal: Blood
Blood (2004) 104 (11): 1070.
https://doi.org/10.1182/blood.V104.11.1070.1070
Published: 2004
Journal Articles

Clinical Relevance of Soluble HLA-I as Compared to b2-MicroglobulinLevels in Non-Hodgkin’s Lymphoma and Hodgkin’s Disease.

Maher Albitar, MD, Julie M. Vose, MD, Marcella M. Johnson, PhD, Kim-Ann Do, PhD, Amanda Day, BS, Iman Jilani, PhD, Hagop Kantarjian, MD, Michael Keating, MD, Susan M. O’Brien, MD, Srdan Verstovsek, MD, James O. Armitage, MD, Francis J. Giles, MD
Journal: Blood
Blood (2004) 104 (11): 3270.
https://doi.org/10.1182/blood.V104.11.3270.3270
Published: 2004
Journal Articles

Thrombopoietin as an Independent Prognostic Marker in Chronic Lymphocytic Leukemia.

Charles Asa Koller, MD, B. Nebiyou Bekele, PhD, Xian Zhou, PhD, Charles Park, BS, Zeef Estrove, MD, Susan O’Brien, MD, Michael Keating, MD, Iman Jilani, PhD, Francis J. Giles, MD, Hagop M. Kantarjian, MD, Maher Albitar, MD
Journal: Blood
Blood (2004) 104 (11): 1905.
https://doi.org/10.1182/blood.V104.11.1905.1905
Published: 2004